- This event has passed.
Cycle 2: Biomarkers Development
May 20, 2022
Sponsor: Alzheimer’s Drug Discovery Foundation
Deadlines:
Letter of Intent: May 20, 2022
Invited Full Proposal: July 22, 2022
Award: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use. Award Amount:
Up to $600,000 based on stage and scope of research.
